Bioshares Biotech Clinical Trial (BBC)

$29.08 0.45 (1.56%)
16:10 EDT BBC Stock Quote Delayed 30 Minutes

3 of the Best Biotech ETFs on the Market

The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.

5 ETFs to Play in July

5 Ultra Cheap PEG Stocks Value Investors Will Love

5 Biotech ETFs for Outsized Gains

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 203,540
PE Ratio -
Volume (Avg. Vol.) 2,212
Day's Range $28.64 - $29.08
52-Week Range $17.77 - $49.28
Dividend & Yield N/A (N/A)